G01N 2405/10
Glycosphingolipids
Official title: Glycosphingolipids, e.g. cerebrosides, gangliosides
G01N2405/10 (Glycosphingolipids) appears on 53 US grants and 82 published applications in this corpus.
Search patents in G01N- Granted patents
- 53
- Published applications
- 82
- Assignees
- 64
- Inventors
- 146
- Latest grant
- 23 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 5 | 0 |
| 2001 | 3 | 2 |
| 2002 | 3 | 2 |
| 2003 | 4 | 2 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 3 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 1 | 3 |
| 2011 | 1 | 7 |
| 2012 | 1 | 5 |
| 2013 | 5 | 0 |
| 2014 | 0 | 4 |
| 2015 | 3 | 8 |
| 2016 | 3 | 5 |
| 2017 | 2 | 4 |
| 2018 | 5 | 6 |
| 2019 | 3 | 3 |
| 2020 | 3 | 4 |
| 2021 | 3 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 2 |
| 2024 | 1 | 3 |
| 2025 | 0 | 6 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and test kits for determining male fertility status23 Jul 2024US 12,044,677 B2Androvia LifeSciences, LLC
- Human monoclonal antibodies to ganglioside GD219 Sep 2023US 11,760,809 B2BioNTech SE
- Molecular probes for imaging of myelin12 Jul 2022US 11,382,991 B2Case Western Reserve University
- Method for the diagnosis of Gaucher's disease17 Aug 2021US 11,092,609 B2Centogene AG
- Antibodies, pharmaceutical compositions and methods22 Jun 2021US 11,041,017 B2Obi Pharma, Inc.
- Quantitative determination method for hex4, lyso-gm1, fuc-glcnac-asn, and lyso-sulfatide included in cerebrospinal fluid14 May 2026US 2026/0133202 A1JCR Pharmaceuticals Co., Ltd.
- Method for detecting lysosomal storage disease biomarkers and kits for performing the method12 Mar 2026US 2026/0072045 A1Universitair Ziekenhuis Antwerpen
- Companion diagnostic assay for globo-h related cancer therapy23 Oct 2025US 2025/0327822 A1Obi Pharma, Inc.
- Method for the in vitro diagnosis of neurogenerative metabolic diseases23 Oct 2025US 2025/0327823 A1Ospedale Pediatrico Bambino Gesu'
- Diagnostic signature9 Oct 2025US 2025/0314671 A1BCAL Diagnostics Limited
Most cited
By later US patents
- Nucleic acid-coupled colorimetric analyte detectors41US 6,306,598 B1The Regents of the University of California · 2001
- Treatment of metastatic colon cancer with b-subunit of shiga toxin34US 7,875,586 B2The Johns Hopkins University · 2011
- Triggered optical biosensor33US 6,297,059 B1The Regents of the University of California · 2001
- β(1-3)-glucan diagnostic assays29US 6,294,321 B1The Collaborative Group, Ltd. · 2001
- Quantitative microarray of intact glycolipid CD1d interaction and correlation with cell-based cytokine production29US 8,383,554 B2Academia Sinica · 2013